Close

Pfizer (PFE) PT Lowered to $36 at JPMorgan

June 1, 2020 7:41 AM EDT
Get Alerts PFE Hot Sheet
Price: $27.75 -0.11%

Rating Summary:
    13 Buy, 20 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE

JPMorgan analyst Chris Schott lowered the price target on Pfizer (NYSE: PFE) to $36.00 (from $37.00) while maintaining a Neutral rating.

The analyst comments "We see a clear inflection in growth for Pfizer after the Lyrica patent expiration in 2019 with a reacceleration of the company’s organic top- and bottom-line growth in the 2020-2025 period (top-line growth of ~5% expected to be above Major Pharma). However, we remain Neutral with valuation reflecting visible near-term growth and another major patent cycle post-2025."



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst PT Change, Hot Comments

Related Entities

JPMorgan